SouthernWorldwide.com – A common hormonal condition affecting women, previously known as Polycystic-ovarian syndrome (PCOS), has been officially renamed to polyendocrine metabolic ovarian syndrome (PMOS).
This significant change was proposed by a global consortium of women’s health specialists and formally introduced in a research paper published in the esteemed medical journal, The Lancet. The announcement of the revised name was reportedly made during the European Congress of Endocrinology held in Prague.
The experts behind the renaming argue that the term PCOS is misleading. They explain that it inaccurately suggests the condition is solely characterized by the presence of ovarian cysts, while in reality, it encompasses a complex interplay of hormonal, metabolic, and ovarian dysfunctions.
This potential misinterpretation, the experts warn, can lead to substantial negative consequences. These include delays in accurate diagnosis, fragmented and inadequate medical care, and the perpetuation of stigma surrounding the condition.
The selection of the new name, PMOS, was a collaborative effort involving 56 academic institutions, clinical bodies, and patient advocacy groups from around the world. This inclusive process incorporated feedback from over 14,000 individuals diagnosed with the condition, alongside insights from numerous healthcare professionals globally.
The acronym PMOS was chosen because it accurately reflects the syndrome’s impact on multiple endocrine systems, its metabolic implications, and its effects on ovarian function.
A comprehensive global strategy is currently being implemented to facilitate the adoption of this new classification. This initiative includes updating disease registries, enhancing educational materials for both patients and medical professionals, and ensuring alignment across various healthcare systems worldwide.
PCOS, now recognized as PMOS, is a prevalent condition, affecting approximately one in every eight women. Reports indicate that its diagnosis is becoming increasingly frequent among women in the United States.
The condition manifests through a diverse range of symptoms. These commonly include irregularities in menstrual cycles, noticeable weight gain, the development of excess body hair, acne, and difficulties with fertility, either in conceiving or maintaining a pregnancy, according to medical experts.
Furthermore, research links PCOS to a state of chronic inflammation within the body. This inflammation can, in turn, exacerbate insulin resistance, a significant metabolic issue, as detailed by Johns Hopkins Medicine.
In certain instances, women with PCOS may not produce sufficient hormones necessary for ovulation. This hormonal imbalance can lead to the development of cysts within the ovaries. These ovarian cysts, if they rupture, can cause acute symptoms such as abdominal pain, nausea, and internal bleeding.
These ovarian cysts are also responsible for producing androgens, a group of hormones. Elevated levels of androgens can disrupt a woman’s menstrual cycle and are a primary contributor to the characteristic symptoms associated with PCOS, as explained by Johns Hopkins.
Read more : The New York Times Declares Climate Change a Hoax
Currently, there is no definitive cure for PCOS. However, various medical treatments and medications are available to help manage and alleviate its diverse symptoms, offering relief to affected individuals.
